18. Spinocerebellar degeneration Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 76 / Drugs : 98 - (DrugBank : 31) / Drug target genes : 44 - Drug target pathways : 65
Previous names | - | ||
---|---|---|---|
Other names | SCD; | ||
Disease group | Neuromuscular diseases | ||
Related info (in Japanese) | - | ||
Designated intractable diseases (in Japanese) | Overview, Diagnostic criteria, etc. (docx), Clinical research form (pdf) | ||
Specific pediatric chronic diseases, Japan (in Japanese) | 11-27-80. spinocerebellar degeneration; SCD | ||
Subtypes | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
18-1. | Spinocerebellar ataxia type I;SCA1; | ||
18-2. | Spinocerebellar ataxia type II;SCA2; | ||
18-3. | Spinocerebellar ataxia type III;SCA3;Machado-Joseph disease; | ||
18-4. | Spinocerebellar ataxia type VI;SCA6; | ||
18-5. | Spinocerebellar ataxia type VII;SCA7; | ||
18-6. | Spinocerebellar ataxia type X;SCA10; | ||
18-7. | Spinocerebellar ataxia type XII;SCA12; | ||
18-8. | Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease; | ||
18-9. | Friedreich ataxia;FRDA; | ||
18-10. | Ataxia with vitamin E deficiency;AVED; | ||
18-11. | Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EOAH; |